The core feature of the 356 patients with LRRK2 Gly2019Ser-associated PD was asymmetrical, tremor-predominant parkinsonism with bradykinesia and rigidity that responded to dopamine replacement and functional neurosurgery. Here, LRRK2 is linked to Parkinson disease.